Surgery Doctors in Meridian, MS Accepting Medicare

10 Surgery doctors found. Showing 1 - 10

Stephen W Tartt, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2111 14th St, Meridian, MS 39301 Phone: 601-693-3834    Fax: 601-484-3225

Sarah Tabb, Surgery Medicare: Not Enrolled in Medicare Practice Location: 2124 14th St, Meridian, MS 39301 Phone: 601-553-6000

Dr. Leslie B. Gray, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1800 12th St, Meridian, MS 39301 Phone: 601-484-6700

Dr. David A. Makey, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1800 12th St, Meridian, MS 39301 Phone: 601-703-9233

William A Billups Iii, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2111 14th St, Meridian, MS 39301 Phone: 601-693-3834    Fax: 601-484-3225

Hans Hunt Tulip, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2111 14th St, Meridian, MS 39301 Phone: 601-693-3834    Fax: 601-693-6275

Johnathan Lee, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1800 12th St, 3rd Floor, Meridian, MS 39301 Phone: 601-703-9970

Dr. Kevin M. Ward, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1800 12th St, Meridian, MS 39301 Phone: 601-703-9223

Daniel D Denison, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2111 14th St, Meridian, MS 39301 Phone: 601-693-3834    Fax: 601-484-3225

Dr. James Howard Wallace, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1600 22nd Ave Fl 3, Meridian, MS 39301 Phone: 601-693-1055    Fax: 601-482-5312

News Archive

Posey StaySafe Bed for European markets

The Posey Company, a leader in the design and manufacture of innovative and reliable patient safety solutions, today officially announced the availability of the Posey StaySafe(TM) Bed, Model 8080, for European markets. The bed has been designed for sale in Holland, France, and Germany; sales to additional European country markets will follow.

Guardian blog interviews researcher regarding artemisinin synthesis discovery

In this post in the Guardian's "The Observer," Mark Honigsbaum, a research associate at the University of Zurich's Institute for Medical History, interviews Peter Seeberger, the director of the Max Planck Institute of Colloids and Interfaces in Potsdam, Germany, about a recent announcement that Seeberger and colleague François Lévesque "have discovered a simple and cost-effective way of synthesizing artemisinin from the waste products of the" sweet wormwood plant from which it is extracted.

Cell Cure, Teva Pharmaceutical enter license option agreement for OpRegen product

BioTime, Inc., Cell Cure Neurosciences Ltd., and Hadasit Bio-Holdings Ltd. jointly announced today that Cell Cure and Teva Pharmaceutical Industries Ltd. have entered into an exclusive license option agreement to develop and commercialize Cell Cure's OpRegen product for the treatment of age-related macular degeneration (AMD).

Participants seek depression treatment post initial screening, according to NDSD study

Screening for Mental Health, Inc., the leading nonprofit provider of online and in-person mental health screening programs, today released results from a follow-up study of participants in the 2008 National Depression Screening Day® (NDSD) online program.

Read more Medical News

› Verified 9 days ago